Inspire Medical Systems I...
(INSP)
undefined
undefined%
At close: undefined
187.83
-0.27%
After-hours Dec 13, 2024, 04:10 PM EST
Company Description
Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally.
The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA.
It also develops a novel, a closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway.
The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.
Inspire Medical Systems Inc.
| Country | United States |
| IPO Date | May 3, 2018 |
| Industry | Medical - Devices |
| Sector | Healthcare |
| Employees | 1,011 |
| CEO | Timothy P. Herbert |
Contact Details
Address: 5500 Wayzata Boulevard Golden Valley, Minnesota United States | |
| Website | https://www.inspiresleep.com |
Stock Details
| Ticker Symbol | INSP |
| Exchange | NYSE |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001609550 |
| CUSIP Number | 457730109 |
| ISIN Number | US4577301090 |
| Employer ID | 26-1377674 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| Timothy P. Herbert | Founder, Chairman, Chief Executive Officer & President |
| John C. Rondoni | Chief Technology Officer |
| Melissa J. Mann | Chief People Officer |
| Richard J. Buchholz | Chief Financial Officer |
| Bryan K. Phillips J.D. | Senior Vice President, General Counsel, Chief Compliance Officer & Corporate Secretary |
| Carlton W. Weatherby | Chief Strategy Officer |
| Dr. Charisse Y. Sparks FAAOS, M.D. | Chief Medical Officer |
| Ezgi Yagci | Vice President of Investor Relations |
| Ivan Lubogo | Senior Vice President of U.S. Sales |
| Randall A. Ban | Chief Commercial Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Nov 12, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
| Nov 12, 2024 | 8-K | Current Report |
| Nov 05, 2024 | 4 | Filing |
| Nov 04, 2024 | 10-Q | Quarterly Report |
| Nov 04, 2024 | 8-K | Current Report |
| Oct 16, 2024 | 4 | Filing |
| Oct 16, 2024 | 4 | Filing |
| Oct 16, 2024 | 4 | Filing |
| Oct 16, 2024 | 4 | Filing |
| Oct 04, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |